Location: Fannin House, Dublin 18, Ireland
Department: Quality & Regulatory
Reports to: Quality & Regulatory Lead-Pharma with a matrix to Quality & Regulatory Lead-Devices
The Quality Compliance Pharmacist is responsible for ensuring compliance with Good Distribution Practice (GDP) and regulatory requirements across pharmaceutical and medical device operations. This includes support of quality systems, product release, validation, and supplier management. The role involves maintaining regulatory licenses, managing pharmacovigilance and vigilance activities, handling audits and CAPAs, and ensuring up-to-date documentation and training programs. The officer also supports compliance with MDR/IVDR, oversees change control processes, and ensures products meet quality standards before distribution, working cross-functionally with internal teams and external partners. The role will also support regulatory, medical information and pharmacovigilance requirements as applicable
Quality Management & Compliance
Regulatory
Vigilance & Safety
Validation & System Control
Training & Development
Supplier & Warehouse Oversight
Product Release
Change Control
Desirable Skills and Experience:
The role demands a well-organised approach, underpinned by the ability to communicate effectively with people at all levels, both verbally and in writing. Reliability, IT literacy and the ability to plan and complete projects to set timelines is essential.
Although the above is a description of the requirements of the role, as stated in your contract of employment, you may be required to carry out other reasonable duties as the Company may require from time to time.
Vital Healthcare operates quality and EHS management systems across all sites and staff agree to comply within the requirements relevant to their role.
FANNIN LTD IS AN EQUAL OPPORTUNITY EMPLOYER

Invested in Energy. DCC is a customer-focused energy business, specialising in the sales, marketing, and distribution of secure, cleaner and competitive energy solutions to commercial, industrial, domestic, and transport customers. Headquartered in Dublin, DCC is listed on the London Stock Exchange and is a constituent of the FTSE 100. In our financial year ended 31 March 2025, DCC generated revenues of £16.1 billion and adjusted operating profit of £609.7 million. DCC has an excellent record, delivering compound annual growth of 13% in continuing adjusted operating profit and unbroken dividend growth of 13% while maintaining high returns on capital employed over 31 years as a public company.